Options Brief: Pharmacyclics

Shares of Pharmacyclics PCYC are lower on the session by 1.47%, trading at $11.37. Overall call volume is now running at 7.17x the daily average, with 9% of all calls traded being purchases on the offer. 4,731 contracts have traded on the session so far. Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases.